Strong Drive for Danish Biotechs
Copenhagen - Many years of strategic investments in life sciences and biotechnology have contributed to building up Denmark as a strong biotech nation. The Danish biotech sector is ranked among the best when comparing the quality of biotech research or the number of biotech patents per inhabitants with other OECD countries. Part of the Danish biotech/pharma industry is concentrated in the Medicon Valley region around Copenhagen and Malmö, Sweden, which is among the leading bio-tech regions in Europe with a unique concentration of universities, research institutions and industry. New initiatives such as bioTEAMsouth (Odense), the biomedical Science Park (Århus) and BioMed Community (Ålborg) are further examples of the growing development of the Danish bio-tech sector. The aim is that Denmark beco-mes even more attractive as an investment opportunity when foreign biotech companies are looking for new places for research and innovation activities. Thus the Government has introduced plans for a new foundation for high technology research and innovation, with biotechnology as one suggested focus area. The foundation will be launched on January 1, 2005. In 2012 its capital base will reach more than Euro2 billion. It is our intention to obtain synergy through private and institutional co-financing from national as well as international sources. Together with the Strategic Research Council, the foundation will be an important driver for Danish biotech research and development, minimizing the gap between research and innovative products.